{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:24:20Z","timestamp":1648718660865},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T00:00:00Z","timestamp":1347494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00292-012-1664-y","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T03:24:17Z","timestamp":1347333857000},"page":"269-272","source":"Crossref","is-referenced-by-count":2,"title":["Translationale Forschung und Diagnostik beim Lungenkarzinom"],"prefix":"10.1007","volume":"33","author":[{"given":"F.","family":"G\u00f6ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Perner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,13]]},"reference":[{"key":"1664_CR1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129\u20132139","journal-title":"N Engl J Med"},{"key":"1664_CR2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ncponc0558","volume":"3","author":"Weinstein","year":"2006","unstructured":"Weinstein IB, Joe AK (2006) Mechanisms of disease: oncogene addiction: a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol 3:448\u2013457","journal-title":"Nat Clin Pract Oncol"},{"key":"1664_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2003.11.005","volume":"14","author":"Pao","year":"2004","unstructured":"Pao W, Miller VA, Kris MG (2004) \u201aTargeting\u2018 the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC). Semin Cancer Biol 14:33\u201340","journal-title":"Semin Cancer Biol"},{"key":"1664_CR4","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","volume":"21","author":"Hirsch","year":"2003","unstructured":"Hirsch FR, Varella-Garcia M, Bunn PA Jr et al (2003) Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21:3798\u20133807","journal-title":"J Clin Oncol"},{"key":"1664_CR5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1183\/09031936.00.16599100","volume":"16","author":"Reinmuth","year":"2000","unstructured":"Reinmuth N, Brandt B, Kunze WP et al (2000) Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer. Eur Respir J 16:991\u2013996","journal-title":"Eur Respir J"},{"key":"1664_CR6","first-page":"603","volume":"7","author":"Ohsaki","year":"2000","unstructured":"Ohsaki Y, Tanno S, Fujita Y et al (2000) Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep 7:603\u2013607","journal-title":"Oncol Rep"},{"key":"1664_CR7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/bjc.1998.106","volume":"77","author":"Volm","year":"1998","unstructured":"Volm M, Rittgen W, Drings P (1998) Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer 77:663\u2013669","journal-title":"Br J Cancer"},{"key":"1664_CR8","first-page":"515","volume":"3","author":"Rusch","year":"1997","unstructured":"Rusch V, Klimstra D, Venkatraman E et al (1997) Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res 3:515\u2013522","journal-title":"Clin Cancer Res"},{"key":"1664_CR9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/bjc.1996.320","volume":"74","author":"Pfeiffer","year":"1996","unstructured":"Pfeiffer P, Clausen PP, Andersen K et al (1996) Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections. Br J Cancer 74:86\u201391","journal-title":"Br J Cancer"},{"key":"1664_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M et al (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448:561\u2013566","journal-title":"Nature"},{"key":"1664_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/JTO.0b013e31815e8b60","volume":"3","author":"Inamura","year":"2008","unstructured":"Inamura K, Takeuchi K, Togashi Y et al (2008) EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. J Thorac Oncol 3:13\u201317","journal-title":"J Thorac Oncol"},{"key":"1664_CR12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1593\/neo.07878","volume":"10","author":"Perner","year":"2008","unstructured":"Perner S, Wagner PL, Demichelis F et al (2008) EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia 10:298\u2013302","journal-title":"Neoplasia"},{"key":"1664_CR13","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","volume":"363","author":"Kwak","year":"2010","unstructured":"Kwak EL, Bang YJ, Camidge DR et al (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363:1693\u20131703","journal-title":"N Engl J Med"},{"key":"1664_CR14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nature06358","volume":"450","author":"Weir","year":"2007","unstructured":"Weir BA, Woo MS, Getz G et al (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893\u2013898","journal-title":"Nature"},{"key":"1664_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/path.2443","volume":"217","author":"Perner","year":"2009","unstructured":"Perner S, Wagner PL, Soltermann A et al (2009) TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol 217:65\u201372","journal-title":"J Pathol"},{"key":"1664_CR16","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ng.465","volume":"41","author":"Bass","year":"2009","unstructured":"Bass AJ, Watanabe H, Mermel CH et al (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41:1238\u20131242","journal-title":"Nat Genet"},{"key":"1664_CR17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/modpathol.2011.49","volume":"24","author":"Wilbertz","year":"2011","unstructured":"Wilbertz T, Wagner P, Petersen K et al (2011) SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol 24:944\u2013953","journal-title":"Mod Pathol"},{"key":"1664_CR18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/1471-2407-11-518","volume":"11","author":"Neumann","year":"2011","unstructured":"Neumann J, Bahr F, Horst D et al (2011) SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 11:518","journal-title":"BMC Cancer"},{"key":"1664_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.oraloncology.2011.05.017","volume":"47","author":"Du","year":"2011","unstructured":"Du L, Yang Y, Xiao X et al (2011) Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. Oral Oncol 47:709\u2013713","journal-title":"Oral Oncol"},{"key":"1664_CR20","doi-asserted-by":"crossref","first-page":"62ra93","DOI":"10.1126\/scitranslmed.3001451","volume":"2","author":"Weiss","year":"2010","unstructured":"Weiss J, Sos ML, Seidel D et al (2010) Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med 2:62ra93","journal-title":"Sci Transl Med"},{"key":"1664_CR21","doi-asserted-by":"crossref","unstructured":"Goeke F, Franzen A, Menon R et al (2012) Rationale for treatment of metastatic squamous cell carcinoma of the lung using FGFR Inhibitors. Chest","DOI":"10.1378\/chest.11-2943"},{"key":"1664_CR22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.oraloncology.2006.01.005","volume":"43","author":"Freier","year":"2007","unstructured":"Freier K, Schwaenen C, Sticht C et al (2007) Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Oral Oncol 43:60\u201366","journal-title":"Oral Oncol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-012-1664-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-012-1664-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-012-1664-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:06:34Z","timestamp":1559027194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-012-1664-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,13]]},"references-count":22,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1664"],"URL":"https:\/\/doi.org\/10.1007\/s00292-012-1664-y","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,13]]}}}